为符合当前决策需求对肾癌患者TNM分期系统的更新：欧洲泌尿外科学会指南小组的提议
A Renewal of the TNM Staging System for Patients with Renal Cancer To Comply with Current Decision-making: Proposal from the European Association of Urology Guidelines Panel.
作者信息
Capitanio Umberto, Bedke Jens, Albiges Laurence, Volpe Alessandro, Giles Rachel H, Hora Milan, Marconi Lorenzo, Klatte Tobias, Abu-Ghanem Yasmin, Dabestani Saeed, Fernández Pello Sergio, Hofmann Fabian, Kuusk Teele, Tahbaz Rana, Powles Thomas, Ljungberg Börje, Bex Axel
机构信息
Department of Urology, San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology/Unit of Urology, Urological Research Institute, IRCCS San Raffaele Hospital, Milan, Italy.
Department of Urology, University Hospital Tübingen, Tübingen, Germany; German Cancer Consortium and German Cancer Research Center, Heidelberg, Germany.
出版信息
Eur Urol. 2023 Jan;83(1):3-5. doi: 10.1016/j.eururo.2022.09.026. Epub 2022 Oct 15.
Over the past decade, only minor changes have been introduced in the TNM staging system for renal cancer. Conversely, many milestones and modifications in management of the disease have been achieved, especially for patients with locally advanced and metastatic cancers. The European Association of Urology guidelines panel proposes a new TNM classification scheme for staging of renal cell carcinoma to reflect these breakthrough clinical improvements.
在过去十年中，肾癌的TNM分期系统仅做了一些微小改动。相反，在该疾病的治疗方面已取得了许多里程碑式进展和改进，尤其是对于局部晚期和转移性癌症患者。欧洲泌尿外科学会指南小组提出了一种新的肾细胞癌分期TNM分类方案，以反映这些突破性的临床进展。
Zotero 插件